Regulatory · source year

1998 regulatory records

12 selected, source-linked regulatory records dated 1998. This is selective source coverage, not a complete timeline.

Dated records

12 selected records.

Peptide profiles

8 connected profiles.

Cited sources

12 distinct public records.

Cited chronology

Dated source records

All record types in 1998 →

December 1998

1 record

Nesiritide

Federal Register notice 98-33915

The Federal Register published notice 98-33915, attributed to FDA and its parent HHS department, on 1998-12-23. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.

Source: Federal Register via GovInfo ↗

→

November 1998

2 records

Glucagon

Federal Register proposed rule 98-29855

The Federal Register published proposed rule 98-29855, attributed to FDA and its parent HHS department, on 1998-11-12. Its official title is “Medical Devices; Exemption From Premarket Notification and Reserved Devices; Class I,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Source: Federal Register via GovInfo ↗

→

September 1998

3 records

Vasopressin

Federal Register notice 98-25713

The Federal Register published notice 98-25713, attributed to FDA and its parent HHS department, on 1998-09-25. Its official title is “Parke-Davis Pharmaceutical Research et al.; Withdrawal of Approval of 14 New Drug Applications and 13 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

Source: Federal Register via GovInfo ↗

→

Bivalirudin

Federal Register notice 98-25360

The Federal Register published notice 98-25360, attributed to FDA and its parent HHS department, on 1998-09-23. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.

Source: Federal Register via GovInfo ↗

→

August 1998

1 record

June 1998

1 record

May 1998

2 records

Leuprolide

Federal Register notice 98-13045

The Federal Register published notice 98-13045, attributed to FDA and its parent HHS department, on 1998-05-18. Its official title is “Environmental Assessments and Findings of No Significant Impact,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Source: Federal Register via GovInfo ↗

→

March 1998

1 record

Mecasermin

Federal Register notice 98-7053

The Federal Register published notice 98-7053, attributed to FDA and its parent HHS department, on 1998-03-19. Its official title is “Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.

Source: Federal Register via GovInfo ↗

→

February 1998

1 record

Glucagon

Federal Register notice 98-2498

The Federal Register published notice 98-2498, attributed to FDA and its parent HHS department, on 1998-02-02. Its official title is “Medical Devices; Exemptions From Premarket Notification and Reserved Devices; Class I,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Source: Federal Register via GovInfo ↗

→